ENDOSERUM

Salmonella Typhimurium Antibody, Equine Origin

Re-17 Derived Mutagenically

For Veterinary Use Only

Cross protective antibodies are recommended for attenuating the effects of Salmonella typhimurium and Escherichia coli in equids when administered prior to challenge. Increases circulating levels of IgG anti-endotoxin antibodies. Also recommended for use in neonatal foals for treatment of failure of passive transfer. Because antibodies may be rapidly depleted during Gram negative diseases, administration should be repeated if signs of endotoxemia recur or persist. Prepared from healthy horses negative for equine infectious anemia (EIA), brucellosis, piroplasmosis, dourine, glanders and anti-red blood cell antibodies.

Administration And Dosage

Shake well before use.

- Administer intravenously 0.7 mL/lb (1.5 mL/kg) of body weight prior to the onset of endotoxemia.

- For treatment of Failure Passive Transfer: Administer intravenously 7.0 mL/lb (15 mL/kg) of body weight.

- Dilute with an equal or larger volume of sterile physiological saline or lactated Ringer’s solution. Warm to room temperature. Administration should not be completed in less than 30 minutes.

ENDOSERUM Caution

Sales restricted to licensed veterinarians. Do not freeze. Store at 2-7°C (35-45°F). Use entire contents when opened. Do not use within 21 days of slaughter. If an anaphylactoid reaction occurs, administer epinephrine.

U.S. Veterinary License No. 345

U.S. Patent No. 5641492

IMMVAC, Inc., Columbia, MO, 65201, U.S.A.

250 Ml, 500 Ml

Nac No.